Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Zoely is approved in the E.U.

Aug. 4, 2011

Novartis enrolls patients in phase II BPS-804 trials

Aug. 4, 2011

Takeda patents new melanin-concentrating hormone MCH1 receptor antagonists

Aug. 4, 2011

Amarin completes remaining studies of AMR-101 required for NDA

Aug. 3, 2011

Protalix replies to FDA complete response letter for taliglucerase alfa

Aug. 3, 2011

Genzyme seeks approval for mipomersen in Europe

Aug. 3, 2011

Trial measures lorcaserin exposure in human cerebrospinal fluid

Aug. 3, 2011

Piramal Life Sciences claims new diacylglycerol O-acyltransferase inhibitors

Aug. 3, 2011

Byetta is safe and effective in Prader-Willi syndrome

Aug. 3, 2011

New GLP-1 analogues and derivatives disclosed by Novo Nordisk

Aug. 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...